{"id":"https://genegraph.clinicalgenome.org/r/074ef25c-aa66-4b59-b505-884c91b22463v1.0","type":"EvidenceStrengthAssertion","dc:description":"*ALG1* was first reported in relation to autosomal recessive ALG1-congenital disorder of glycosylation (also known as congenital disorder of glycosylation type 1k) in 2004 (Grubenmann et al., PMID: 14709599). Common phenotypes in affected individuals include severe developmental delay, intellectual disability, microcephaly, hypotonia, early-onset epilepsy, and facial dysmorphism. Additional variable features include coagulation defects, immunodeficiency, and nephrotic syndrome. The most severely affected patients die during the first years of life. Eleven homozygous and compound heterozygous variants (8 missense, including 3 recurrent; 2 splice, 1 nonsense) that have been reported in 10 probands in eight publications (PMIDs: 14709599, 14973782, 20679665, 22966035, 24157261, 26931382, 27325525, 35221878) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is known to be loss of function. \n\nThis gene-disease relationship is also supported by the biochemical function of *ALG1*, which encodes a protein involved in N-linked glycosylation. Multiple members of the asparagine-linked glycosylation (ALG) family of glycosyltransferases have been implicated in congenital disorders of glycosylation (PMID: 37858231).\n\nIn summary, there is definitive evidence supporting the relationship between *ALG1* and autosomal recessive ALG1-congenital disorder of glycosylation. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on August 7, 2024 (SOP Version 10).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/074ef25c-aa66-4b59-b505-884c91b22463","GCISnapshot":"https://genegraph.clinicalgenome.org/r/98d42afb-c5ce-4518-83ce-aab777f202e6","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/98d42afb-c5ce-4518-83ce-aab777f202e6_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2024-08-07T19:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/98d42afb-c5ce-4518-83ce-aab777f202e6_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2024-10-08T04:04:46.776Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98d42afb-c5ce-4518-83ce-aab777f202e6_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b949200d-231e-4db5-8163-a0f812dede33_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34c74db9-aa2f-4251-a95e-dd6fd43f9170","type":"EvidenceLine","dc:description":"Recurrent variant (PMIDs 22966035, 26931382, 35221878).","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34c74db9-aa2f-4251-a95e-dd6fd43f9170_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"p.Ser359Leu was unable to rescue impaired growth or hypoglycosylation of a standard biomarker in an alg1-deficient yeast strain complementation assay.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/34c74db9-aa2f-4251-a95e-dd6fd43f9170_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22966035","allele":{"id":"https://genegraph.clinicalgenome.org/r/a3d0a243-6a74-454b-87f4-a6d94da8a937","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_019109.5(ALG1):c.1076C>T (p.Ser359Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394673720"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b949200d-231e-4db5-8163-a0f812dede33","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22966035","rdfs:label":"Morava Family 1 IV/13","ageType":"AgeAtReport","ageUnit":"Years","ageValue":21,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a3d0a243-6a74-454b-87f4-a6d94da8a937"},"phenotypes":["obo:HP_0005484","obo:HP_0008947","obo:HP_0001263","obo:HP_0001249","obo:HP_0000486"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/34c74db9-aa2f-4251-a95e-dd6fd43f9170_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ce0f64fc-53da-4871-966a-6277088a3fe6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ab49dc1-40d1-414c-aaaf-e11284462745","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ab49dc1-40d1-414c-aaaf-e11284462745_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"p.Ala298Val was unable to rescue impaired growth or\nhypoglycosylation of a standard biomarker in an alg1-deficient yeast strain complementation assay.)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5ab49dc1-40d1-414c-aaaf-e11284462745_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22966035","allele":{"id":"https://genegraph.clinicalgenome.org/r/9882733c-c94b-40ff-9ea0-f1d39ab0d2eb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_019109.5(ALG1):c.893C>T (p.Ala298Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394681977"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2aa39d13-3a36-4ec7-8365-b19154aee6bd","type":"EvidenceLine","dc:description":"Recurrent variant (PMIDs 22966035, 24157261)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2aa39d13-3a36-4ec7-8365-b19154aee6bd_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional complementation of the temperature sensitive ALG1-1 mutant S. cerevisiae\nPRY56 showed impairment. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2aa39d13-3a36-4ec7-8365-b19154aee6bd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22966035","allele":{"id":"https://genegraph.clinicalgenome.org/r/fb58bceb-026c-416c-a46d-e51cb71bd711","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_019109.5(ALG1):c.1145T>C (p.Met382Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394673896"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ce0f64fc-53da-4871-966a-6277088a3fe6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22966035","rdfs:label":"Morava Family 3 II/3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/fb58bceb-026c-416c-a46d-e51cb71bd711"},{"id":"https://genegraph.clinicalgenome.org/r/9882733c-c94b-40ff-9ea0-f1d39ab0d2eb"}],"phenotypes":["obo:HP_0007663","obo:HP_0012736","obo:HP_0011968","obo:HP_0001250","obo:HP_0000252","obo:HP_0001977","obo:HP_0001251","obo:HP_0008936","obo:HP_0002540","obo:HP_0025722"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/2aa39d13-3a36-4ec7-8365-b19154aee6bd_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5ab49dc1-40d1-414c-aaaf-e11284462745_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/05ff26d4-1f2f-4519-bdce-8c72529b87ec_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db857eea-64c1-4282-a193-2bd2b42927a7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db857eea-64c1-4282-a193-2bd2b42927a7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"p.Ala360Val was unable to rescue impaired growth or\nhypoglycosylation of a standard biomarker in an alg1-deficient yeast strain complementation assay. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/db857eea-64c1-4282-a193-2bd2b42927a7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26931382","allele":{"id":"https://genegraph.clinicalgenome.org/r/54ef3077-fa21-47b4-8d8e-3dcdef3f8d1b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_019109.5(ALG1):c.1079C>T (p.Ala360Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA223551"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3c750160-23e9-4bc4-a759-55b4395af867","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c750160-23e9-4bc4-a759-55b4395af867_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26931382","allele":{"id":"https://genegraph.clinicalgenome.org/r/6b9d7e24-ef66-45ff-a130-221a8d864539","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_019109.5(ALG1):c.209-1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA394678973"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/05ff26d4-1f2f-4519-bdce-8c72529b87ec","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26931382","rdfs:label":"Ng Proband 35","allele":[{"id":"https://genegraph.clinicalgenome.org/r/6b9d7e24-ef66-45ff-a130-221a8d864539"},{"id":"https://genegraph.clinicalgenome.org/r/54ef3077-fa21-47b4-8d8e-3dcdef3f8d1b"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Dx: (1) the occurrence of at least one abnormal carbohydrate deficient transferrin (CDT) test result indicating a type I CDG, or (2) molecular findings showing the presence of homozygous or compound heterozygous variants in ALG1","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/db857eea-64c1-4282-a193-2bd2b42927a7_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/3c750160-23e9-4bc4-a759-55b4395af867_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/5caa3c88-50eb-4156-bc7d-4b6eca19f9ca_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d161d5b3-6d29-4b7f-ade2-16c05ac13951","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d161d5b3-6d29-4b7f-ade2-16c05ac13951_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional complementation of the temperature sensitive ALG1-1 mutant S. cerevisiae\nPRY56 showed impairment. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d161d5b3-6d29-4b7f-ade2-16c05ac13951_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24157261","allele":{"id":"https://genegraph.clinicalgenome.org/r/fb58bceb-026c-416c-a46d-e51cb71bd711"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/06580cc7-4aeb-48a9-838c-f262db7c30b2","type":"EvidenceLine","dc:description":"Recurrent variant (PMIDs 20679665, 24157261). ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06580cc7-4aeb-48a9-838c-f262db7c30b2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional complementation of the temperature sensitive ALG1-1 mutant S. cerevisiae\nPRY56 showed impairment.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/06580cc7-4aeb-48a9-838c-f262db7c30b2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24157261","allele":{"id":"https://genegraph.clinicalgenome.org/r/251d1487-16aa-4498-9e2c-0d961b91af51","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_019109.5(ALG1):c.1312C>T (p.Arg438Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA277165747"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5caa3c88-50eb-4156-bc7d-4b6eca19f9ca","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24157261","rdfs:label":"Rohlfing_1","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/251d1487-16aa-4498-9e2c-0d961b91af51"},{"id":"https://genegraph.clinicalgenome.org/r/fb58bceb-026c-416c-a46d-e51cb71bd711"}],"firstTestingMethod":"PCR","phenotypeFreeText":"Type I isoelectric focusing pattern of serum transferrin in patient fibroblasts showed hypoglycosylation much more pronounced than that found in the most common CDG, CDG-Ia. This patient was born to non-consanguineous parents of Dutch and German origin. The course of pregnancy was uneventful up to the 33rd week when premature rupture of membranes and premature labor led to preterm delivery. Recurrent seizures, episodes of prolonged apnoea and bradycardia finally resulted in cardiac arrest. After resuscitating the patient twice, the treatment was limited to palliative therapy and the patient died from cardiovascular failure.","phenotypes":["obo:HP_0002104","obo:HP_0001250","obo:HP_0008360","obo:HP_0002014","obo:HP_0001276","obo:HP_0001928","obo:HP_0011968"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d161d5b3-6d29-4b7f-ade2-16c05ac13951_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/06580cc7-4aeb-48a9-838c-f262db7c30b2_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a1e2617f-c466-48c7-84a1-e0c507b454bd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c9dfec66-ca2b-4d21-92cd-25d5e1e5f0dc","type":"EvidenceLine","dc:description":"Recurrent variant (PMIDs 20679665, 24157261). This variant was not given recurrence points as  ID/Autism GCEP maximum allowable score per proband is 2.0pts.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c9dfec66-ca2b-4d21-92cd-25d5e1e5f0dc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"p.Arg438Trp was unable to rescue impaired growth or\nhypoglycosylation of a standard biomarker in an alg1-deficient yeast strain complementation assay (PMID 26931382).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c9dfec66-ca2b-4d21-92cd-25d5e1e5f0dc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20679665","allele":{"id":"https://genegraph.clinicalgenome.org/r/251d1487-16aa-4498-9e2c-0d961b91af51"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/46991ae1-d8a1-47dc-ad61-53e0b00e554b","type":"EvidenceLine","dc:description":"Recurrent variant (unrelated Dupré patient 1 and Dupré patient 5 carry this variant).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46991ae1-d8a1-47dc-ad61-53e0b00e554b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20679665","allele":{"id":"https://genegraph.clinicalgenome.org/r/1456eacf-4daf-43d0-a53a-ee656f433aa5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_019109.5(ALG1):c.1188T>A (p.Cys396Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA277974"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a1e2617f-c466-48c7-84a1-e0c507b454bd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20679665","rdfs:label":"Dupré Patient 1","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/1456eacf-4daf-43d0-a53a-ee656f433aa5"},{"id":"https://genegraph.clinicalgenome.org/r/251d1487-16aa-4498-9e2c-0d961b91af51"}],"detectionMethod":"Western blot followed by single gene sequencing ","firstTestingMethod":"Other","phenotypeFreeText":"Biochemical studies in patient cell lines showed an accumulation of the second intermediate in the biosynthesis of LLO, GlcNAc2-PP-dolichol, as well as a selective defect of MT1 activity (less than 10% of wildtype).","phenotypes":["obo:HP_0001250","obo:HP_0011968","obo:HP_0000306","obo:HP_0000233","obo:HP_0008897","obo:HP_0001263","obo:HP_0001252","obo:HP_0000505","obo:HP_0001321","obo:HP_0000252"],"secondTestingMethod":"Other","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/46991ae1-d8a1-47dc-ad61-53e0b00e554b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c9dfec66-ca2b-4d21-92cd-25d5e1e5f0dc_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/bb73bf4a-2ed4-4cf3-882a-e4ac60bf9a0a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ed7bd1bf-6e06-435b-b993-18cf156e4b64","type":"EvidenceLine","dc:description":"Recurrent variant (PMIDs: 26931382, 14973782, 14973778)","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ed7bd1bf-6e06-435b-b993-18cf156e4b64_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Patient fibroblasts with p.Ser258Leu variant are highly unstable, resulting in near absence of protein expression in patient fibroblasts (PMID: 26931382). ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ed7bd1bf-6e06-435b-b993-18cf156e4b64_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27325525","allele":{"id":"https://genegraph.clinicalgenome.org/r/12cfa5d5-f5ec-4f97-8283-1fab00308265","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_019109.5(ALG1):c.773C>T (p.Ser258Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA223556"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/bb73bf4a-2ed4-4cf3-882a-e4ac60bf9a0a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27325525","rdfs:label":"Harshman Patient 18","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/12cfa5d5-f5ec-4f97-8283-1fab00308265"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Carbohydrate-deficient transferrin analysis showed elevation in the CDG mono/di ratio and CDG A/DI oligosaccharide ratio, suggestive of a CDG type I pattern. Required permanent ventilatory support due to seizure-related apnea. ","phenotypes":["obo:HP_0006879","obo:HP_0000316","obo:HP_0000960","obo:HP_0001252","obo:HP_0000093","obo:HP_0009815","obo:HP_0008677","obo:HP_0012443","obo:HP_0006817","obo:HP_0011968","obo:HP_0000028","obo:HP_0000252","obo:HP_0000969","obo:HP_0001250","obo:HP_0040010","obo:HP_0008897"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ed7bd1bf-6e06-435b-b993-18cf156e4b64_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/31059f1d-8423-49ba-8278-de1344181218_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcb10f01-c145-4fff-b362-f74eb4be1ab2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcb10f01-c145-4fff-b362-f74eb4be1ab2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The transfection of alg1-1 yeasts expressing the Ser150Arg variant failed to restore growth of alg1-1 yeasts, which supports pathogenicity. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/dcb10f01-c145-4fff-b362-f74eb4be1ab2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14709599","allele":{"id":"https://genegraph.clinicalgenome.org/r/d2ac4774-6ecf-402d-8649-9f1056ce1635","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_019109.5(ALG1):c.450C>G (p.Ser150Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA277941"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0b631047-a1af-4823-82c3-0770f0d58e52","type":"EvidenceLine","dc:description":"Recurrent variant (PMIDs: 26931382, 14973782, 14973778).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b631047-a1af-4823-82c3-0770f0d58e52_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expressing wild type ALG1 in agl1-1 yeast restores normal growth patterns. However, expressing the patient ALG1 alleles in alg1-1 yeast did not restore growth indicating that both alleles have altered function. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0b631047-a1af-4823-82c3-0770f0d58e52_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14709599","allele":{"id":"https://genegraph.clinicalgenome.org/r/12cfa5d5-f5ec-4f97-8283-1fab00308265"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/31059f1d-8423-49ba-8278-de1344181218","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14709599","rdfs:label":"Grubenmann Proband","ageType":"AgeAtReport","ageUnit":"Months","ageValue":6,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/d2ac4774-6ecf-402d-8649-9f1056ce1635"},{"id":"https://genegraph.clinicalgenome.org/r/12cfa5d5-f5ec-4f97-8283-1fab00308265"}],"firstTestingMethod":"PCR","phenotypeFreeText":"Coagulation problems related to low antithrombin-III (12% of normal values). Isoelectric focusing of serum transferrin showed a typical CDG-I pattern with decreased tetrasialo and with increased disialo and asialotransferrin. Phosphomannomutase activity measured in the patient fibroblasts yielded an intermediate value of 2.2 mU/mg protein (normal range 5.3+- 1.7 mU/mg protein).","phenotypes":["obo:HP_0040187","obo:HP_0001410","obo:HP_0001250","obo:HP_0000618","obo:HP_0001263","obo:HP_0001252","obo:HP_0001928"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/dcb10f01-c145-4fff-b362-f74eb4be1ab2_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/0b631047-a1af-4823-82c3-0770f0d58e52_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c61bdbe1-a25b-40f1-b65a-fe2b9ecaab99_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f656777-92c2-4ee1-ba35-22ef402492d7","type":"EvidenceLine","dc:description":"Recurrent variant (PMIDs: 26931382, 14973782, 14973778).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f656777-92c2-4ee1-ba35-22ef402492d7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Glycosylation of CPY impaired in mutant yeast cells","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1f656777-92c2-4ee1-ba35-22ef402492d7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14973782","allele":{"id":"https://genegraph.clinicalgenome.org/r/12cfa5d5-f5ec-4f97-8283-1fab00308265"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e588e109-0237-4b39-9b60-3bedd8f4cfe7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e588e109-0237-4b39-9b60-3bedd8f4cfe7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Glycosylation of CPY impaired in mutant yeast cells","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e588e109-0237-4b39-9b60-3bedd8f4cfe7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14973782","allele":{"id":"https://genegraph.clinicalgenome.org/r/31f515fa-8d71-43ec-aa24-9cd4edb284c0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_019109.5(ALG1):c.1025A>C (p.Gln342Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA277940"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c61bdbe1-a25b-40f1-b65a-fe2b9ecaab99","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14973782","rdfs:label":"Kranz Patient 1 (NK)","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":10,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/12cfa5d5-f5ec-4f97-8283-1fab00308265"},{"id":"https://genegraph.clinicalgenome.org/r/31f515fa-8d71-43ec-aa24-9cd4edb284c0"}],"firstTestingMethod":"PCR","phenotypeFreeText":"Type I isoelectric focusing pattern of serum transferrin in patient fibroblasts showed hypoglycosylation much more pronounced than that found in the most common CDG, CDG-Ia.","phenotypes":["obo:HP_0025405","obo:HP_0033349","obo:HP_0001928","obo:HP_0002059","obo:HP_0000252"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/1f656777-92c2-4ee1-ba35-22ef402492d7_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e588e109-0237-4b39-9b60-3bedd8f4cfe7_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/98d42afb-c5ce-4518-83ce-aab777f202e6_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/12f846ae-1bd2-4578-b2c4-cc0d7eeaa1fc_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22966035","rdfs:label":"Morava Family 1 ","estimatedLodScore":3.66,"family":{"id":"https://genegraph.clinicalgenome.org/r/12f846ae-1bd2-4578-b2c4-cc0d7eeaa1fc","type":"Family","rdfs:label":"Morava Family 1 ","member":{"id":"https://genegraph.clinicalgenome.org/r/b949200d-231e-4db5-8163-a0f812dede33"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":10,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0001249","obo:HP_0000486","obo:HP_0008947","obo:HP_0005484","obo:HP_0001263"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/b949200d-231e-4db5-8163-a0f812dede33"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/fc9ee86e-c0b6-4727-b610-3c578b01567f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9674190-2abe-4a2c-917f-e3c598c2185e","type":"EvidenceLine","dc:description":"ID/Autism GCEP maximum allowable score per proband is 2.0pts","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9674190-2abe-4a2c-917f-e3c598c2185e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26931382","allele":{"id":"https://genegraph.clinicalgenome.org/r/b7fb33ca-f152-4b64-b9c8-2c0a4955e6b7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_019109.5(ALG1):c.961+1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7890123"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fc9ee86e-c0b6-4727-b610-3c578b01567f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26931382","rdfs:label":"Ng Proband 39","allele":{"id":"https://genegraph.clinicalgenome.org/r/b7fb33ca-f152-4b64-b9c8-2c0a4955e6b7"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Dx: (1) the occurrence of at least one abnormal carbohydrate deficient transferrin (CDT) test result indicating a type I CDG, or (2) molecular findings showing the presence of homozygous or compound heterozygous variants in ALG1.","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/e9674190-2abe-4a2c-917f-e3c598c2185e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/688c4675-cfbc-4f24-9049-912b9f2eee9f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8736e9de-8abb-4acd-aaa4-dbb7cd83b63d","type":"EvidenceLine","dc:description":"Recurrent variant (PMIDs 22966035, 26931382, 35221878).","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8736e9de-8abb-4acd-aaa4-dbb7cd83b63d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"p.Ser359Leu was unable to rescue impaired growth or\nhypoglycosylation of a standard biomarker in an alg1-deficient yeast strain complementation assay.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8736e9de-8abb-4acd-aaa4-dbb7cd83b63d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35221878","allele":{"id":"https://genegraph.clinicalgenome.org/r/a3d0a243-6a74-454b-87f4-a6d94da8a937"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/688c4675-cfbc-4f24-9049-912b9f2eee9f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35221878","rdfs:label":"Öncül Case Report","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a3d0a243-6a74-454b-87f4-a6d94da8a937"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Isoelectric focusing showed a CDG-I-pattern with increased disialotransferrin (11.79%; normal range 2–2.5%), decreased tetrasialotransferrin (52.81%; normal range 64–80%) and decreased\npentasialotransferrin (10.79%; normal range 12–18%).","phenotypes":["obo:HP_0000252","obo:HP_0002015","obo:HP_0001250","obo:HP_0011342","obo:HP_0001508","obo:HP_0001252"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8736e9de-8abb-4acd-aaa4-dbb7cd83b63d_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/98d42afb-c5ce-4518-83ce-aab777f202e6_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98d42afb-c5ce-4518-83ce-aab777f202e6_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dfa054af-fbc5-460c-b38a-4458a6b67898","type":"EvidenceLine","dc:description":"Type I congenital disorders of glycosylation are caused by defects that affect the biosynthesis of N-linked glycoproteins. Multiple members of the asparagine-linked glycosylation (ALG) family of glycosyltransferases have been implicated in these disorders, including ALG1, ALG2, ALG3, ALG6, ALG8, ALG9 and ALG12.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ca459b0-5f4e-4e2a-89eb-766eef10d83e","type":"Finding","dc:description":"ALG1-congenital disorder of glycosylation is diagnosed by type I transferrin isoform pattern on isoelectric focusing showing decreased tetrasialotransferrin and increased asialotransferrin and disialotransferrin. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37858231","rdfs:label":"Transferrin Isoforms Analysis","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1}],"evidenceStrength":"Definitive","sequence":9173,"specifiedBy":"GeneValidityCriteria10","strengthScore":13,"subject":{"id":"https://genegraph.clinicalgenome.org/r/p-HGsey3FbQ","type":"GeneValidityProposition","disease":"obo:MONDO_0012052","gene":"hgnc:18294","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_98d42afb-c5ce-4518-83ce-aab777f202e6-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}